Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Aliphatic Azides as Selective Cysteine Labeling Reagents for Integral Membrane Proteins.

Szymanski D, Papanastasiou M, Pandarinathan L, Zvonok N, Janero DR, Pavlopoulos S, Vouros P, Makriyannis A.

J Med Chem. 2018 Dec 27;61(24):11199-11208. doi: 10.1021/acs.jmedchem.8b01302. Epub 2018 Dec 10.

PMID:
30444608
2.

Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice.

Li Y, Chen Z, Paonessa JD, Meinl W, Bhattacharya A, Glatt H, Vouros P, Zhang Y.

Cancer Med. 2018 Nov;7(11):5604-5610. doi: 10.1002/cam4.1779. Epub 2018 Oct 10.

3.

The integration of LC-MS and NMR for the analysis of low molecular weight trace analytes in complex matrices.

Gathungu RM, Kautz R, Kristal BS, Bird SS, Vouros P.

Mass Spectrom Rev. 2018 Jul 19. doi: 10.1002/mas.21575. [Epub ahead of print] Review.

PMID:
30024655
4.

Differential Mobility Spectrometry-Mass Spectrometry (DMS-MS) in Radiation Biodosimetry: Rapid and High-Throughput Quantitation of Multiple Radiation Biomarkers in Nonhuman Primate Urine.

Chen Z, Coy SL, Pannkuk EL, Laiakis EC, Fornace AJ Jr, Vouros P.

J Am Soc Mass Spectrom. 2018 Aug;29(8):1650-1664. doi: 10.1007/s13361-018-1977-z. Epub 2018 May 7.

PMID:
29736597
5.

Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl.

Chen Z, Zhang Y, Vouros P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 15;1087-1088:49-60. doi: 10.1016/j.jchromb.2018.04.041. Epub 2018 Apr 24. Review.

6.

Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation.

Vera NB, Chen Z, Pannkuk E, Laiakis EC, Fornace AJ Jr, Erion DM, Coy SL, Pfefferkorn JA, Vouros P.

J Mass Spectrom. 2018 Jul;53(7):548-559. doi: 10.1002/jms.4085.

7.

James Augustus McCloskey (1936-2017).

Vouros P, Desiderio D.

Mass Spectrom Rev. 2018 Mar;37(2):105-106. doi: 10.1002/mas.21557. Epub 2018 Feb 7. No abstract available.

PMID:
29415345
8.

John Hayes (1940-2017).

Vouros P, Desiderio D.

Mass Spectrom Rev. 2017 May;36(3):471-472. doi: 10.1002/mas.21533. No abstract available.

PMID:
28394457
9.

Metabolism of selective 20-epi-vitamin D3 analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D3.

Flarakos CC, Weiskopf A, Robinson M, Wang G, Vouros P, Sasso GJ, Uskokovic MR, Reddy GS.

Steroids. 2017 Mar;119:18-30. doi: 10.1016/j.steroids.2016.12.013. Epub 2017 Jan 12.

PMID:
28089927
10.

Obituary: Klaus Biemann.

Desiderio DM, Vouros P.

Mass Spectrom Rev. 2017 Jan;36(1):110-112. doi: 10.1002/mas.21524. Epub 2016 Nov 18. No abstract available.

PMID:
27862149
11.

Rapid and High-Throughput Detection and Quantitation of Radiation Biomarkers in Human and Nonhuman Primates by Differential Mobility Spectrometry-Mass Spectrometry.

Chen Z, Coy SL, Pannkuk EL, Laiakis EC, Hall AB, Fornace AJ Jr, Vouros P.

J Am Soc Mass Spectrom. 2016 Oct;27(10):1626-36. doi: 10.1007/s13361-016-1438-5. Epub 2016 Jul 8.

12.

Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons.

Klaene JJ, Flarakos C, Glick J, Barret JT, Zarbl H, Vouros P.

J Chromatogr A. 2016 Mar 25;1439:112-123. doi: 10.1016/j.chroma.2015.10.057. Epub 2015 Oct 26.

13.

Differential mobility spectrometry/mass spectrometry history, theory, design optimization, simulations, and applications.

Schneider BB, Nazarov EG, Londry F, Vouros P, Covey TR.

Mass Spectrom Rev. 2016 Oct;35(6):687-737. doi: 10.1002/mas.21453. Epub 2015 May 11. Review.

PMID:
25962527
14.

The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage.

Bhattacharya A, Klaene JJ, Li Y, Paonessa JD, Stablewski AB, Vouros P, Zhang Y.

Oncotarget. 2015 Jan 20;6(2):836-45.

15.

Obituary.

Heck A, Desiderio DM, Uggerud E, Lebrilla C, Vouros P.

Mass Spectrom Rev. 2014 Nov-Dec;33(6):415-6. doi: 10.1002/mas.21446. Epub 2014 Sep 29. No abstract available. Erratum in: Mass Spectrom Rev. 2015 Jan-Feb;34(1):1.

PMID:
25267091
17.

Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR.

Gathungu RM, Bird SS, Sheldon DP, Kautz R, Vouros P, Matson WR, Kristal BS.

Anal Biochem. 2014 Jun 1;454:23-32. doi: 10.1016/j.ab.2014.01.020. Epub 2014 Mar 18.

18.

Understanding gas phase modifier interactions in rapid analysis by differential mobility-tandem mass spectrometry.

Kafle A, Coy SL, Wong BM, Fornace AJ Jr, Glick JJ, Vouros P.

J Am Soc Mass Spectrom. 2014 Jul;25(7):1098-113. doi: 10.1007/s13361-013-0808-5. Epub 2014 Jan 23.

19.

Extending the dynamic range of the ion trap by differential mobility filtration.

Hall AB, Coy SL, Kafle A, Glick J, Nazarov E, Vouros P.

J Am Soc Mass Spectrom. 2013 Sep;24(9):1428-36.

20.

A differential mobility spectrometry/mass spectrometry platform for the rapid detection and quantitation of DNA adduct dG-ABP.

Kafle A, Klaene J, Hall AB, Glick J, Coy SL, Vouros P.

Rapid Commun Mass Spectrom. 2013 Jul 15;27(13):1473-80. doi: 10.1002/rcm.6591.

21.

Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.

Rhieu SY, Annalora AJ, Wang G, Flarakos CC, Gathungu RM, Vouros P, Sigüeiro R, Mouriño A, Schuster I, Palmore GT, Reddy GS.

J Cell Biochem. 2013 Oct;114(10):2293-305. doi: 10.1002/jcb.24576.

PMID:
23606409
22.

Structural characterization of plasma metabolites detected via LC-electrochemical coulometric array using LC-UV fractionation, MS, and NMR.

Bird SS, Sheldon DP, Gathungu RM, Vouros P, Kautz R, Matson WR, Kristal BS.

Anal Chem. 2012 Nov 20;84(22):9889-98. doi: 10.1021/ac302278u. Epub 2012 Nov 6.

23.

The role of mass spectrometry in the analysis of vitamin D compounds.

Gathungu RM, Flarakos CC, Reddy GS, Vouros P.

Mass Spectrom Rev. 2013 Jan-Feb;32(1):72-86. doi: 10.1002/mas.21353. Epub 2012 Sep 20. Review.

PMID:
22996283
24.

The analysis of DNA adducts: the transition from (32)P-postlabeling to mass spectrometry.

Klaene JJ, Sharma VK, Glick J, Vouros P.

Cancer Lett. 2013 Jun 28;334(1):10-9. doi: 10.1016/j.canlet.2012.08.007. Epub 2012 Sep 4. Review.

25.

Development of rapid methodologies for the isolation and quantitation of drug metabolites by differential mobility spectrometry - mass spectrometry.

Hall AB, Coy SL, Nazarov E, Vouros P.

Int J Ion Mobil Spectrom. 2012 Sep 1;15(3). doi: 10.1007/s12127-012-0111-3.

27.

GenoMass software: a tool based on electrospray ionization tandem mass spectrometry for characterization and sequencing of oligonucleotide adducts.

Sharma VK, Glick J, Liao Q, Shen C, Vouros P.

J Mass Spectrom. 2012 Apr;47(4):490-501. doi: 10.1002/jms.2054.

29.

Rapid separation and characterization of cocaine and cocaine cutting agents by differential mobility spectrometry-mass spectrometry.

Hall AB, Coy SL, Nazarov EG, Vouros P.

J Forensic Sci. 2012 May;57(3):750-6. doi: 10.1111/j.1556-4029.2011.02033.x. Epub 2012 Jan 11.

PMID:
22235847
30.
31.

Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention.

Paonessa JD, Ding Y, Randall KL, Munday R, Argoti D, Vouros P, Zhang Y.

Cancer Res. 2011 Jun 1;71(11):3904-11. doi: 10.1158/0008-5472.CAN-11-0396. Epub 2011 Apr 12.

32.

A new insight into the role of rat cytochrome P450 24A1 in metabolism of selective analogs of 1α,25-dihydroxyvitamin D₃.

Rhieu SY, Annalora AJ, Gathungu RM, Vouros P, Uskokovic MR, Schuster I, Palmore GT, Reddy GS.

Arch Biochem Biophys. 2011 May 1;509(1):33-43. doi: 10.1016/j.abb.2011.02.004. Epub 2011 Feb 19.

33.

Oligonucleotide Adducts as Biomarkers for DNA Damages. Analysis by Mass Spectrometry Coupled to Separation Methods.

Liao Q, Vouros P.

Adv Chromatogr. 2011;49:195-256. No abstract available.

PMID:
26434238
34.

Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues.

Ding Y, Paonessa JD, Randall KL, Argoti D, Chen L, Vouros P, Zhang Y.

Carcinogenesis. 2010 Nov;31(11):1999-2003. doi: 10.1093/carcin/bgq183. Epub 2010 Sep 1.

35.

The vanishing zero revisited: thresholds in the age of genomics.

Zarbl H, Gallo MA, Glick J, Yeung KY, Vouros P.

Chem Biol Interact. 2010 Mar 19;184(1-2):273-8. doi: 10.1016/j.cbi.2010.01.031. Epub 2010 Jan 28.

36.

An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues.

Randall KL, Argoti D, Paonessa JD, Ding Y, Oaks Z, Zhang Y, Vouros P.

J Chromatogr A. 2010 Jun 18;1217(25):4135-43. doi: 10.1016/j.chroma.2009.11.006. Epub 2009 Nov 10.

37.

The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.

Glick J, Xiong W, Lin Y, Noronha AM, Wilds CJ, Vouros P.

J Mass Spectrom. 2009 Aug;44(8):1241-8. doi: 10.1002/jms.1605.

38.

Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3.

Laverny G, Penna G, Uskokovic M, Marczak S, Maehr H, Jankowski P, Ceailles C, Vouros P, Smith B, Robinson M, Reddy GS, Adorini L.

J Med Chem. 2009 Apr 23;52(8):2204-13. doi: 10.1021/jm801365a.

PMID:
19309155
39.
40.

Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites.

Lin Y, Schiavo S, Orjala J, Vouros P, Kautz R.

Anal Chem. 2008 Nov 1;80(21):8045-54. doi: 10.1021/ac801049k. Epub 2008 Oct 4.

41.

Metabolomic analysis and signatures in motor neuron disease.

Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, Harrison S, Vouros P, Flarakos J, Vigneau-Callahan K, Matson TD, Newhall KM, Beal MF, Brown RH Jr, Kaddurah-Daouk R.

Metabolomics. 2005;1(2):101-108.

42.

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Wood JT, Williams JS, Pandarinathan L, Courville A, Keplinger MR, Janero DR, Vouros P, Makriyannis A, Lammi-Keefe CJ.

Clin Chem Lab Med. 2008;46(9):1289-95. doi: 10.1515/CCLM.2008.242.

43.

Metabolite identification using a nanoelectrospray LC-EC-array-MS integrated system.

Schiavo S, Ebbel E, Sharma S, Matson W, Kristal BS, Hersch S, Vouros P.

Anal Chem. 2008 Aug 1;80(15):5912-23. doi: 10.1021/ac800507y. Epub 2008 Jun 25.

44.

Short peptide induces an "uncultivable" microorganism to grow in vitro.

Nichols D, Lewis K, Orjala J, Mo S, Ortenberg R, O'Connor P, Zhao C, Vouros P, Kaeberlein T, Epstein SS.

Appl Environ Microbiol. 2008 Aug;74(15):4889-97. doi: 10.1128/AEM.00393-08. Epub 2008 May 30.

45.

Review.

Vouros P.

J Am Soc Mass Spectrom. 2007 Nov;18(11):R1-2. doi: 10.1016/j.jasms.2007.08.011. No abstract available.

PMID:
27517706
46.

Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.

Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A.

Anal Chem. 2007 Aug 1;79(15):5582-93. Epub 2007 Jun 29.

PMID:
17600384
47.
48.

Characterization of phosphorylation sites on Tpl2 using IMAC enrichment and a linear ion trap mass spectrometer.

Black TM, Andrews CL, Kilili G, Ivan M, Tsichlis PN, Vouros P.

J Proteome Res. 2007 Jun;6(6):2269-76. Epub 2007 May 2.

PMID:
17472361
49.

Investigation of enzymatic behavior of benzonase/alkaline phosphatase in the digestion of oligonucleotides and DNA by ESI-LC/MS.

Liao Q, Chiu NH, Shen C, Chen Y, Vouros P.

Anal Chem. 2007 Mar 1;79(5):1907-17. Epub 2007 Jan 30.

PMID:
17261027
50.

Endocannabinoid metabolomics: a novel liquid chromatography-mass spectrometry reagent for fatty acid analysis.

Williams J, Pandarinathan L, Wood J, Vouros P, Makriyannis A.

AAPS J. 2006 Oct 20;8(4):E655-60.

Supplemental Content

Loading ...
Support Center